共 50 条
- [2] A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients with Type 2 Diabetes in Long-Term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial (vol 19, pg 399, 2018) JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2019, 20 (07) : 925 - 925